These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 24992621

  • 21. Protective effects of angiotensin II type-1 receptor blockade with olmesartan on spinal cord ischemia-reperfusion injury: an experimental study on rats.
    Güler A, Sahin MA, Ucak A, Onan B, Inan K, Oztaş E, Arslan S, Uysal B, Demirkiliç U, Tatar H.
    Ann Vasc Surg; 2010 Aug; 24(6):801-8. PubMed ID: 20638619
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of intrathecal caffeic acid phenethyl ester and methylprednisolone on oxidant/antioxidant status in traumatic spinal cord injuries.
    Gocmez C, Celik F, Kamasak K, Kaplan M, Uzar E, Arıkanoglu A, Evliyaoglu O.
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jan; 76(1):20-4. PubMed ID: 24871822
    [Abstract] [Full Text] [Related]

  • 24. Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury.
    Kaptanoglu E, Solaroglu I, Surucu HS, Akbiyik F, Beskonakli E.
    Acta Neurochir (Wien); 2005 Apr; 147(4):405-12; discussion 412. PubMed ID: 15696267
    [Abstract] [Full Text] [Related]

  • 25. Neuroprotective effects of infliximab in experimental spinal cord ischemic injury.
    Guven C, Borcek AO, Cemil B, Kurt G, Yildirim Z, Ucankus NL, Kilic N, Ceviker N.
    J Clin Neurosci; 2010 Dec; 17(12):1563-7. PubMed ID: 20817464
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of the Effects of Methotrexate and Methylprednisolone in Spinal Cord Injury in Rats.
    Meng H, Liu Y, Li K, Li J.
    Drug Res (Stuttg); 2015 Aug; 65(8):437-41. PubMed ID: 25333652
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.
    Ucak A, Onan B, Güler A, Sahin MA, Kılıçkaya O, Oztaş E, Uysal B, Arslan S, Yılmaz AT.
    Ann Vasc Surg; 2011 Jul; 25(5):686-95. PubMed ID: 21724106
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the effects of octreotide and melatonin in preventing nerve injury in rats with experimental spinal cord injury.
    Erol FS, Kaplan M, Tiftikci M, Yakar H, Ozercan I, Ilhan N, Topsakal C.
    J Clin Neurosci; 2008 Jul; 15(7):784-90. PubMed ID: 18407497
    [Abstract] [Full Text] [Related]

  • 32. Neuroprotective effects of infliximab in experimental spinal cord injury.
    Kurt G, Ergün E, Cemil B, Börcek AO, Börcek P, Gülbahar O, Ceviker N.
    Surg Neurol; 2009 Mar; 71(3):332-6, discussion 336. PubMed ID: 18440605
    [Abstract] [Full Text] [Related]

  • 33. Protective role of methylprednisolone and heparin in ischaemic-reperfusion injury of the rat testicle.
    Mertoğlu C, Senel U, Cayli S, Tas U, Küskü Kiraz Z, Özyurt H.
    Andrologia; 2016 Sep; 48(7):737-44. PubMed ID: 26626546
    [Abstract] [Full Text] [Related]

  • 34. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H, Sener G, Cetinel S, Velioğlu-Oğünç A, Yeğen BC.
    Eur J Pharmacol; 2007 Feb 14; 557(1):69-75. PubMed ID: 17173892
    [Abstract] [Full Text] [Related]

  • 35. Neuroprotective effects of rosuvastatin against traumatic spinal cord injury in rats.
    Kahveci R, Gökçe EC, Gürer B, Gökçe A, Kisa U, Cemil DB, Sargon MF, Kahveci FO, Aksoy N, Erdoğan B.
    Eur J Pharmacol; 2014 Oct 15; 741():45-54. PubMed ID: 25084223
    [Abstract] [Full Text] [Related]

  • 36. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
    Okutan O, Solaroglu I, Beskonakli E, Taskin Y.
    J Clin Neurosci; 2007 Apr 15; 14(4):364-8. PubMed ID: 17236773
    [Abstract] [Full Text] [Related]

  • 37. Olfactory bulb implantation and methylprednisolone administration in the treatment of spinal cord injury in rats.
    Carrillo-Ruiz JD, Andrade P, Silva F, Vargas G, Maciel-Navarro MM, Jiménez-Botello LC.
    Neurosci Lett; 2009 Oct 02; 462(1):39-44. PubMed ID: 19560518
    [Abstract] [Full Text] [Related]

  • 38. Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury.
    Can M, Gul S, Bektas S, Hanci V, Acikgoz S.
    Acta Anaesthesiol Scand; 2009 Sep 02; 53(8):1068-72. PubMed ID: 19519725
    [Abstract] [Full Text] [Related]

  • 39. Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats.
    Ozkan E, Yardimci S, Dulundu E, Topaloğlu U, Sehirli O, Ercan F, Velioğlu-Oğünç A, Sener G.
    J Surg Res; 2010 Mar 02; 159(1):588-94. PubMed ID: 19515388
    [Abstract] [Full Text] [Related]

  • 40. The Biochemical, Histopathological and Clinical Comparison of the Neuroprotective Effects of Subcutaneous Adalimumab and Intravenous Methylprednisolone in an Experimental Compressive Spinal Cord Trauma Model.
    Celik H, Karatay M, Erdem Y, Yildirim AE, Sertbas I, Karatay E, Kul H, Guvenc Y, Koksal I, Menekse G, Alagoz F, Kertmen HH, Caydere M.
    Turk Neurosurg; 2016 Mar 02; 26(4):622-31. PubMed ID: 27400112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.